Partner Content Partner Content Less than 3 weeks to SMi's 3rd Annual Drug Discovery Chemist... 3 weeks to SMi's 3rd Annual Drug Discovery Chemistry
News Call for better regulation of AI-based medical products Products based on artificial intelligence should be regulated like drugs, and those that are deemed unsafe should be removed from the market, according to a new report.
News Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI Artificial intelligence and machine learning company InveniAI has joined with Kyowa Hakko Kirin to harness the power of technology for drug discovery.
Partner Content Partner Content Drug Discovery Chemistry - Speaker Interviews with GSK &... Exclusive Speaker Interviews Released with GSK & Roche
News Novo begins R&D tie-up with AI biotech e-Therapeutics Novo Nordisk has signed a deal with UK biotech e-Therapeutics to use its AI-based drug discovery technology to find new therapies for type 2 diabetes.
Events Partner Content SMi's 3rd Annual Drug Discovery Chemistry Conference SMi's 3rd Annual Drug Discovery Chemistry
News Gilead strikes again, penning $5bn deal to buy Tubulis Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
